Novavax Inc (NVAX)

[chrismiss_everyday]

Consider Novavax and Serum Institute’s under-the-radar collaboration for Malaria Vaccine

“Praha Vaccines is a subsidiary of the Cyrus Poonawalla Group, the parent company of Serum Institute of India focused on manufacturing immuno-biologicals.

In March, Serum Institute of India and Novavax signed a commercial license agreement to leverage Novavax’s Matrix-M vaccine adjuvant with the institute’s malaria vaccine candidate.

Novavax president and CEO Stanley Erck said: “This acquisition provides the vital assets required to produce more than one billion doses per year.“

Now, couple that with recent news of:

“Joining the company's leadership team as chief medical officer is Filip Dubovsky, an AstraZeneca veteran. Dubovsky joins Novavax directly from the British drugmaker, where he served as head of clinical engagement and policy, plus as chief medical officer for clinical affairs. Before that role, he oversaw a portfolio of more than two dozen malaria vaccines at the PATH Malaria Vaccine Initiative.”

Yes, Novavax is well situated for NanoFlu, as well as Coronavirus, and the RSV vaccine too.

Everything is lining up for Novavax’s entire pipeline to be brought into play within 2-3 years, if not sooner.

New global vaccination powerhouse.